Novartis is buying dry-eye medicine brand ‘Xiidra’ from Takeda Pharmaceutical for up to $5.3 billion as the Swiss pharma-maker refreshes its ophthalmic medicines portfolio with a potential blockbuster. The deal calls for $3.4 billion up front and milestone payments up to $1.9 billion, Novartis said.
The Department of Health-Abu Dhabi decided to withdraw 20 batches medical products used in catheterisation and other healthcare operations from the Emirate because of their possibility of causing serious infection to patients if they were not immediately substituted with good ones.
Despite strong legislations, India still grapples with the malaise of counterfeit medicines being sold in the open market and online. In fact I recently came across a report which said that about 20 per cent of the drugs manufactured in India are adulterated. It is an unhealthy prognosis but apart from that India
The world of alternative medicine and homeopathy is vast and can be somewhat confusing to those who choose to go down the natural route. This week we are taking a deeper look at what exactly homeopathy entails and how it could work for you.
Neopharma, a leading global pharmaceutical company based in the UAE and GlaxoSmithKline (GSK) the global science-led healthcare company, have announced the launch of the first ever locally produced batch of medicines,
Although nutritional and herbal supplements may be useful, they aren’t risk-free, which is why it’s important that your doctor knows which ones and how much you are taking.
We’re crawling on your skin. Teeming under your toenails. And lurking on your doorknobs and countertops. We’re drug-resistant microbes, immune to all but your strongest antibiotics.
President Rodrigo “Rody” Duterte signed an executive order for a sharp reduction of as much as 56 per cent in the maximum current prices of about 120 essential medicines that have gone beyond the reach especially of poor Filipinos, a senior cabinet official revealed on Monday.
Stem cells are magic that need follow-up for best results, says Dr Steven Victor, an American Board Certified Specialist in Regenerative Medicine and Regenerative Cosmetic Dermatology, in an exclusive Facebook Live interview with Gulf Today.
Eleven pharma companies led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing sector since 2018, according to a Reuters analysis, in a drive to better control production of the world’s priciest medicines.